LFG
DYN icon

Larson Financial Group’s Dyne Therapeutics DYN Stock Holding History

Larson Financial Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7K Hold
796
– – ﹤0.01% 2074
2026
Q1 		$14.4K Buy
796
+774
+3,518% +$13.3K ﹤0.01% 2027
2025
Q4 		$430 Buy
22
+3
+16% +$57 ﹤0.01% 3152
2025
Q3 		$240 Buy
+19
New +$217 ﹤0.01% 3235
2025
Q2 		– Sell
-46
Closed -$481 – 3341
2025
Q1 		$481 Buy
+46
New +$658 ﹤0.01% 2588

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Larson Financial Group's DYN Position: Q2 2026 in Review

Larson Financial Group held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 796 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

Larson Financial Group first reported a position in DYN in Q1 2025 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Larson Financial Group held 796 shares of Dyne Therapeutics worth $17.7K as of Q2 2026.
  • Larson Financial Group left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2074 holding.
  • Larson Financial Group first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.